Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis

This study evaluated the daptomycin activity against two methicillin-resistant Staphylococcus epidermidis (MRSE) clinical isolates with different vancomycin susceptibilities: MRSE-375, with a vancomycin MIC of 2 μg/ml, and NRS6, a glycopeptide-intermediate S. epidermidis (GISE) strain with a vancomy...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: García-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Cervera, C., Ninot, S., Falces, C., Mestres, C. A., Gatell, J. M., Jiménez de Anta, M. T., Miró, J. M.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2010
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897304/
https://ncbi.nlm.nih.gov/pubmed/20421394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01011-09
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires